HIT! High Impact Clinical Trials – Why and How - International Society of Nephrology Events

DavidWheeler Chair United KingdomUniversity College London

Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong

Time	Session

09:00 09:18	What Have We Learned From CONVINCE? HIT2-1
09:18 09:36	Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease HIT2-2
09:36 09:54	A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) HIT2-3
09:54 10:12	Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease HIT2-4
10:12 10:30	Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage HIT2-5